The danger hypothesis - Potential role in idiosyncratic drug reactions

Toxicology

Volumn 181-182, Issue , 2002, Pages 55-63

  Pirmohamed, Munir ^a   Naisbitt, Dean J ^a   Gordon, Fraser ^a   Park, B Kevin ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Adverse drug reaction; Antigen; Idiosyncratic; Immune response

Indexed keywords

AMINOPHENAZONE; ANESTHETIC AGENT; ANTIBIOTIC AGENT; COTRIMOXAZOLE; CYTOKINE; DAPSONE; HALOTHANE; HAPTEN; LEPROSTATIC AGENT; NOMIFENSINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE; SULFAMETHOXAZOLE; TEMAFLOXACIN; ZIMELDINE;

ADVERSE DRUG REACTION; ANTIGEN PRESENTATION; ARTICLE; CLINICAL FEATURE; DISEASE PREDISPOSITION; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG TOLERANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHESIS; IMMUNE RESPONSE; IMMUNE SYSTEM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; VIRUS INFECTION;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIGEN-PRESENTING CELLS; DRUG HYPERSENSITIVITY; HUMANS; IMMUNE SYSTEM; PHARMACEUTICAL PREPARATIONS; SULFAMETHOXAZOLE;

EID: 4244183558     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(02)00255-X     Document Type: Article

References (51)

1. Anderson C.C., Matzinger P. Danger: the view from the bottom of the cliff. Semin. Immunol. 12:2000;231-238.
2. Bedard K., Smith S., Cribb A. Sequential assessment of an antidrug antibody response in a patient with a systemic delayed-onset sulphonamide hypersensitivity syndrome reaction. Br. J. Dermat. 142:2000;253-258.
3. Bessems J.G., Vermeulen N.P. Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit. Rev. Toxicol. 31:2001;55-138.
4. Bigby M. Rates of cutaneous reactions to drugs. Arch. Dermatol. 137:2001;765-770.
5. Burkhart C., von Greyerz S., Depta J.P., Naisbitt D.J., Britschgi M., Park K.B., Pichler W.J. Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells. Br. J. Pharmacol. 132:2001;623-630.
6. Carr A., Cooper D.A. Pathogenesis and management of HIV-associated drug hypersensitivity. AIDS Clin. Rev. 96:1995;65-97.
7. Choquet-Kastylevsky G., Santolaria N., Tedone R., Aujoulat M., Descotes J. Induction of delayed-type hypersensitivity to sulfamethoxazole in mice: role of metabolites. Toxicol. Lett. 119:2001;183-192.
8. Cribb A.E., Miller M., Leeder J.S., Hill J., Spielberg S.P. Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione: implications for idiosyncratic toxicity. Drug Metab. Dispos. 19:1991;900-906.
9. Cribb A.E., Spielberg S.P., Griffin G.P. N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes. Drug Metab. Dispos. 23:1995;406-414.
10. Cribb A.E., Lee B.L., Trepanier L.A., Spielberg S.P. Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis. Adverse Drug React. Toxicol. Rev. 15:1996;9-50.
11. Curtsinger J.M., Schmidt C.S., Mondino A., Lins D.C., Kedl R.M., Jenkins M.K., Mescher M.F. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. J. Immunol. 162:1999;3256-3262.
12. Gallucci S., Matzinger P. Danger signals: SOS to the immune system. Curr. Opin. Immunol. 13:2001;114-119.
13. Gallucci S., Lolkema M., Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5:1999;1249-1255.
14. Gill H.J., Maggs J.L., Madden S., Pirmohamed M., Park B.K. The effect of fluconazole and ketoconazole on the metabolism of sulphamethoxazole. Br. J. Clin. Pharmacol. 42:1996;347-353.
15. Gill H.J., Hough S.J., Naisbitt D.J., Maggs J.L., Kitteringham N.R., Pirmohamed M., Park B.K. The relationship between the disposition and immunogenicity of sulfamethoxazole in the rat. J. Pharmacol. Exp. Therap. 282:1997;795-801.
16. Gruchalla R.S., Pesenko R.D., Do T.T., Skiest D.J. Sulfonamide-induced reactions in desensitized patients with AIDS - the role of covalent protein haptenation by sulfamethoxazole. J. Allergy Clin. Immunol. 101:1998;371-378.
17. Gut J., Christen U., Huwyler J. Mechanisms of halothane toxicity: novel insights. Pharmacol. Therap. 58:1993;133-155.
18. Hertl M., Jugert F., Merk H.F. Cd8(+) dermal t-cells from a sulfamethoxazole-induced bullous exanthem proliferate in response to drug-modified liver-microsomes. Br. J. Dermatol. 132:1995;215-220.
19. Hess D.A., Sisson M.E., Suria H., Wijsman J., Puvanesasingham R., Madrenas J., Rieder M.J. Cytotoxicity of sulfonamide reactive metabolites: apoptosis and selective toxicity of CD8(+) cells by the hydroxylamine of sulfamethoxazole. FASEB J. 13:1999;1688-1698.
20. Holtzman M.J., Green J.M., Jayaraman S., Arch R.H. Regulation of T cell apoptosis. Apoptosis. 5:2000;459-471.
21. Knowles S.R., Uetrecht J., Shear N.H. Idiosyncratic drug reactions: the reactive metabolite syndromes. Lancet. 356:2000;1587-1591.
22. Lazarou J., Pomeranz B.H., Corey P.N. Incidence of adverse drug reactions in hospitalized patients - a meta-analysis of prospective studies. J. Am. Med. Assoc. 279:1998;1200-1205.
23. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:1994;991-1045.
24. Mitra A.K., Thummel K.E., Kalhorn T.F., Kharasch E.D., Unadkat J.D., Slattery J.T. Inhibition of sulfamethoxazole hydroxylamine formation by fluconazole in human liver microsomes and healthy volunteers. Clin. Pharmacol. Therap. 59:1996;332-340.
25. Naisbitt D.J., O'Neill P.M., Pirmohamed M., Park B.K. Synthesis and reactions of nitroso sulfamethoxazole with biological nucleophiles-implications for immune-mediated toxicity. Bioorganic Med. Chem. Lett. 6:1996;1511-1516.
26. Naisbitt D.J., Hough S.J., Gill H.J., Pirmohamed M., Kitteringham N.R., Park B.K. Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity. Br. J. Pharmacol. 126:1999;1393-1407.
27. Naisbitt D.J., Gordon S.F., Pirmohamed M., Park B.K. Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment. Drug Safety. 23:2000;483-507.
28. Naisbitt D.J., Vilar J., Stalford A., Wilkins E.G.L., Pirmohamed M., Park B.K. Plasma cysteine and decreased reduction of nitroso sulphamethoxazole with HIV infection. AIDS Res. Hum. Retrov. 16:2000;1929-1938.
29. Naisbitt D.J., Gordon S.F., Pirmohamed M., Burkhart C., Cribb A.E., Pichler W.J., Park B.K. Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo. Br. J. Pharmacol. 133:2001;295-305.
30. Naisbitt D.J., Williams D.P., Pirmohamed M., Kitteringham N.R., Park B.K. Reactive metabolites and their role in adverse drug reactions. Curr. Opin. Allergy Clin. Immunol. 1:2001;317-325.
31. Nyfeler B., Pichler W.J. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity [Full text delivery]. Clin. Exp. Allergy. 27:1997;175-181.
32. Park B.K., Coleman J.W., Kitteringham N.R. Drug disposition and drug hypersensitivity. Biochem. Pharmacol. 36:1987;581-590.
33. Park B.K., Pirmohamed M., Kitteringham N.R. Idiosyncratic drug reactions: a mechanistic evaluation of risk factors. Br. J. Clin. Pharmacol. 34:1992;377-395.
34. Park B.K., Pirmohamed M., Kitteringham N.R. The role of drug disposition in drug hypersensitivity: a chemical, molecular and clinical perspective. Chem. Res. Toxicol. 11:1998;969-988.
35. Park B.K., Naisbitt D.J., Gordon S.F., Kitteringham N.R., Pirmohamed M. Metabolic activation in drug allergies. Toxicology. 158:2001;11-23.
36. Pichler W.J., Schnyder B., Zanni M.P., Hari Y., vonGreyerz S. Role of T cells in drug allergies. Allergy. 53:1998;225-232.
37. Pirmohamed M., Park B.K. HIV and drug allergy. Curr. Opin. Allergy Clin. Immunol. 1:2001;345-347.
38. Pirmohamed M., Breckenridge A.M., Kitteringham N.R., Park B.K. Adverse drug reactions. Br. Med. J. 316:1998;1295-1298.
39. Pirmohamed M., Alfirevic A., Vilar J., Stalford A., Wilkins E.G., Sim E., Park B.K. Association analysis of drug metabolizing enzyme gene polymorphisms in HIV-positive patients with co-trimoxazole hypersensitivity. Pharmacogenetics. 10:2000;705-713.
40. Reilly T.P., Lash L.H., Doll M.A., Hein D.W., Woster P.M., Svensson C.K. A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. J. Invest. Dermatol. 114:2000;1164-1173.
41. Rich J.D., Sullivan T., Greineder D., Kazanjian P.H. Trimethoprim/sulfamethoxazole incremental dose regimen in human immunodeficiency virus-infected persons. Ann. Allergy Asthma Immunol. 79:1997;409-414.
42. Rieder M.J., Uetrecht J.P., Shear N.H., Cannon M., Miller M., Spielberg S.P. Diagnosis of sulfonamide hypersensitivity reactions by in-vitro 'rechallenge' with hydroxylamine metabolites. Ann. Internal Med. 110:1989;286-289.
43. Rieder M.J., Krause R., Bird I.A., Dekaban G.A. Toxicity of sulfonamide-reactive metabolites in HIV-infected, htlv-infected, and noninfected cells. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 8:1995;134-140.
44. Schnyder B., Mauri-Hellweg D., Zanni M., Bettens F., Pichler W.J. Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alpha/beta T cell clones. J. Clin. Invest. 100:1997;136-141.
45. Schnyder B., Burkhart C., Schnyder-Frutig K., von Greyerz S., Naisbitt D.J., Pirmohamed M., Park B.K., Pichler W.J. Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals. J. Immunol. 164:2000;6647-6654.
46. Shi Y., Zheng W., Rock K.L. Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. Proc. Natl. Acad. Sci. USA. 97:2000;14590-14595.
47. Sullivan J.R., Shear N.H. The drug hypersensitivity syndrome: what is the pathogenesis? Arch. Dermatol. 137:2001;357-364.
48. Uetrecht J.P. New concepts in immunology relevant to idiosyncratic drug reactions: the 'danger hypothesis' and innate immune system. Chem. Res. Toxicol. 12:1999;387-395.
49. van der Ven A.J.A.M., Koopmans P.P., Vree T.B., van der Meer J.W. Adverse reactions to co-trimoxazole in HIV-infection. Lancet. ii:1991;431-433.
50. Vance R.E. Cutting edge: cutting edge commentary: a Copernican revolution? Doubts about the danger theory. J. Immunol. 165:2000;1725-1728.
51. Wong I.C., Mawer G.E., Sander J.W. Factors influencing the incidence of lamotrigine-related skin rash. Ann. Pharmacotherapy. 33:1999;1037-1042.